New perspectives in the treatment of idiopathic pulmonary fibrosis

Therapeutic Advances in Respiratory Disease
Paola RoglianiCesare Saltini

Abstract

Idiopathic pulmonary fibrosis (IPF) is the most frequent idiopathic interstitial pneumonia with a prevalence ranging from 5 to 15 per 100,000 persons, and above 175 per 100,000 in the older population. IPF is a relentlessly progressive fibrotic lung disorder leading to death within a median duration of 3 years. It was hypothesized in the 1970s that pulmonary fibrosis initiates as an "alveolitis" progressing to interstitial fibrosis with connective tissue deposition, derangement of the lung architecture and functional impairment. However, in vitro studies indicated that alveolar/bronchiolar injured epithelial cells can drive the fibrotic process in the absence of macrophages and with minimal inflammation. This, together with the inability of classic immunosuppressive therapy to cure IPF, generated new pathogenesis paradigms and intense research into the role of the lack or the excessive production of anti-fibrotic or profibrotic mediators, oxidant injury, exaggerated coagulation, thus leading to investigate new treatment strategies. Preliminary results of some of such trials have shown significant reductions in lung function decline, disease exacerbation and mortality.

References

May 1, 1992·Clinical and Experimental Immunology·C Prior, P L Haslam
Aug 1, 1991·American Journal of Respiratory Cell and Molecular Biology·N KhalilA H Greenberg
Mar 1, 1991·The Journal of Experimental Medicine·E P SampaioG Kaplan
Oct 1, 1990·The Journal of Clinical Investigation·H N AntoniadesM Selman
Jan 1, 1990·The American Review of Respiratory Disease·J StrauszR Ferlinz
Feb 1, 1989·The American Review of Respiratory Disease·A M CantinR G Crystal
Jun 1, 1987·The Journal of Clinical Investigation·A M CantinR G Crystal
Jan 1, 1986·Respiration; International Review of Thoracic Diseases·A GulsvikJ R Vale
Apr 1, 1971·The Quarterly Journal of Medicine·C H Brown, M Turner-Warwick
Nov 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·S I RennardR G Crystal
Jul 1, 1981·The Journal of Clinical Investigation·G W HunninghakeR G Crystal
Mar 1, 1994·The European Respiratory Journal·A MeyerH Magnussen
Feb 1, 1997·American Journal of Respiratory and Critical Care Medicine·J P Lynch, W J McCune
Aug 1, 1997·American Journal of Respiratory and Critical Care Medicine·S H ParkR P Michel
Aug 1, 1997·American Journal of Respiratory and Critical Care Medicine·S ImokawaA Takada
May 1, 1998·American Journal of Respiratory and Critical Care Medicine·A L Katzenstein, J L Myers
Sep 2, 1998·European Journal of Nuclear Medicine·D J KwekkeboomP M Van Hagen
Dec 9, 1998·Clinical and Experimental Immunology·B GrigoloA Facchini
Jan 7, 1999·The European Respiratory Journal·M KolbM Schmidt
Jul 27, 1999·The Journal of Biological Chemistry·H Nagase, J F Woessner
Aug 6, 1999·Frontiers in Neuroendocrinology·Y C Patel
Aug 10, 1999·Lancet·L P Nicod
Oct 21, 1999·The New England Journal of Medicine·R M Du Bois

❮ Previous
Next ❯

Citations

Apr 27, 2010·Acta Pharmacologica Sinica·Li-jun ChenGuang-mei Yan
Mar 5, 2010·Respirology : Official Journal of the Asian Pacific Society of Respirology·Ross C KlingsbergJoseph A Lasky
Sep 8, 2010·Fibrogenesis & Tissue Repair·Glenda TrujilloCory M Hogaboam
Apr 1, 2014·Fibrogenesis & Tissue Repair·Dominik Bettenworth, Florian Rieder
Sep 8, 2015·Journal of Proteomics·C LandiP Rottoli
Oct 23, 2009·British Journal of Pharmacology·Terence Peters, Peter J Henry
Jul 10, 2012·Revista portuguesa de pneumologia·Z A AytemurK Yildiz
May 26, 2009·Respiratory Medicine·E BargagliP Rottoli
Feb 8, 2011·Arthritis Research & Therapy·Hiroshi ItoShoichi Ozaki

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.